Agilent Technologies (NYSE:A) Stock Bumped Down to “Hold” by Wall Street Zen

04 Oct 2026, 02:12 by Amy Steele · The Cerbat Gem

Wall Street Zen cut shares of Agilent Technologies (NYSE:A – Free Report) from a buy rating to a hold rating in a research note issued to investors on Saturday,Wall Street Zen reports.

A has been the topic of a number of other reports. UBS Group started coverage on shares of Agilent Technologies in a research note on Wednesday, September 9th. They issued a “neutral” rating and a $165.00 price target on the stock. Citigroup upped their price objective on shares of Agilent Technologies from $185.00 to $190.00 and gave the stock a “buy” rating in a report on Thursday, August 27th. Sanford C. Bernstein lifted their target price on shares of Agilent Technologies from $155.00 to $180.00 and gave the company an “outperform” rating in a report on Thursday, August 27th. Morgan Stanley boosted their target price on Agilent Technologies from $160.00 to $175.00 and gave the company an “overweight” rating in a research report on Wednesday, August 12th. Finally, Jefferies Financial Group began coverage on Agilent Technologies in a research note on Thursday, July 9th. They set a “hold” rating and a $135.00 price target on the stock. One equities research analyst has rated the stock with a Strong Buy rating, fourteen have issued a Buy rating and five have given a Hold rating to the company. Based on data from MarketBeat, Agilent Technologies has an average rating of “Moderate Buy” and a consensus price target of $170.33.

Read Our Latest Stock Analysis on A

Agilent Technologies Stock Performance

Shares of Agilent Technologies stock opened at $167.83 on Friday. Agilent Technologies has a 52 week low of $108.35 and a 52 week high of $177.05. The business’s fifty day simple moving average is $152.80 and its 200-day simple moving average is $133.41. The firm has a market cap of $47.32 billion, a PE ratio of 33.04, a price-to-earnings-growth ratio of 2.55 and a beta of 1.21. The company has a quick ratio of 1.56, a current ratio of 2.05 and a debt-to-equity ratio of 0.50.

Agilent Technologies (NYSE:A – Get Free Report) last released its quarterly earnings results on Wednesday, August 26th. The medical research company reported $1.62 earnings per share for the quarter, topping analysts’ consensus estimates of $1.49 by $0.13. The business had revenue of $1.88 billion during the quarter, compared to analysts’ expectations of $1.84 billion. Agilent Technologies had a return on equity of 24.45% and a net margin of 19.53%.The company’s revenue was up 8.1% compared to the same quarter last year. During the same period in the prior year, the business posted $1.37 EPS. Agilent Technologies has set its Q4 2026 guidance at 1.710-1.740 EPS and its FY 2026 guidance at 6.180-6.210 EPS. Equities analysts forecast that Agilent Technologies will post 6.2 earnings per share for the current year.

Agilent Technologies Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, October 28th. Stockholders of record on Tuesday, October 6th will be paid a $0.2550 dividend. The ex-dividend date of this dividend is Tuesday, October 6th. This represents a $1.02 annualized dividend and a dividend yield of 0.6%. Agilent Technologies’s dividend payout ratio (DPR) is presently 20.08%.

Insider Buying and Selling at Agilent Technologies

In related news, Director Mikael Dolsten sold 634 shares of Agilent Technologies stock in a transaction that occurred on Friday, September 4th. The shares were sold at an average price of $151.38, for a total value of $95,974.92. Following the completion of the transaction, the director owned 4,924 shares in the company, valued at approximately $745,395.12. The trade was a 11.41% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink.

Institutional Investors Weigh In On Agilent Technologies

A number of hedge funds have recently added to or reduced their stakes in A. State Street Corp increased its position in shares of Agilent Technologies by 0.7% during the second quarter. State Street Corp now owns 12,854,230 shares of the medical research company’s stock worth $1,710,658,000 after acquiring an additional 89,598 shares during the period. Wellington Management Group LLP boosted its holdings in Agilent Technologies by 2.7% in the second quarter. Wellington Management Group LLP now owns 7,454,686 shares of the medical research company’s stock valued at $990,206,000 after purchasing an additional 198,253 shares during the period. Deutsche Bank AG grew its stake in Agilent Technologies by 17.1% during the 2nd quarter. Deutsche Bank AG now owns 7,008,634 shares of the medical research company’s stock worth $930,957,000 after purchasing an additional 1,024,516 shares in the last quarter. Bank of New York Mellon Corp grew its stake in Agilent Technologies by 87.4% during the 2nd quarter. Bank of New York Mellon Corp now owns 5,233,964 shares of the medical research company’s stock worth $695,227,000 after purchasing an additional 2,440,360 shares in the last quarter. Finally, Cantillon Capital Management LLC increased its holdings in Agilent Technologies by 0.8% during the 4th quarter. Cantillon Capital Management LLC now owns 3,115,638 shares of the medical research company’s stock worth $423,945,000 after purchasing an additional 23,493 shares during the period.

Agilent Technologies Company Profile

(Get Free Report)

Agilent Technologies, Inc is an analytical measurement and laboratory technology company serving the life sciences, diagnostics, pharmaceutical, chemical, environmental, food, energy and academic research markets. Its solutions help laboratories analyze the composition, quality and performance of materials, biological samples and other substances.